Transforming healthcare to support our customers
Iñaki Ereño, Group CEO, commented: "We are at the halfway point of our 3x100 Strategy1 and we are encouraged to see more customers than ever choose Bupa which is driving strong performance as we scale the business. This is enabling us to invest further in our digital and in-person health provision to make it even easier for our customers to access high-quality care in a way that’s convenient for them.”
Performance headlines
- Insurance customers increased by 12% to 49.7m, health provision customers increased 8% to 15.5m and aged care closing occupancy remained high at 94%.
- As a result of this strong customer growth and price increases, revenue increased by 10% to £9.9bn. Combined with a 1ppt improvement in the Combined Operating Ratio (COR)2 of our insurance business to 94%, this drove a 21% increase in underlying profit to £594m at constant exchange rates (CER).
- Statutory profit before tax of £559m was up 12% at actual exchange rates (AER).
- Solvency II capital coverage ratio of 189% is above the top end of Bupa’s working range, reflecting the Bupa Group’s strong capital position underpinned by the short-duration profile of its insurance liabilities.
Strategic progress
- Our drive to implement customer experience improvements has helped us reach a global average Net Promoter Score (NPS) of 74, up +4.5 pts year-on-year and +2.1 pts over the last six months, and 7.3 points since the start of the strategy. When compared to the same period last year, 96% of our business units improved their NPS and 70% achieved an NPS score of over 70.
- We have continued to expand the number of health provision sites available to our customers with 95 additional sites in the last year (+23 over the last six months) across hospitals, clinics and dental. In June 2026, we announced the acquisition of Partnered Health Group in Australia, subject to regulatory approval.
- Since the start of the project in 2025, we have opened 53 Mindplaces across six countries (+7 over the last six months). We now have a total of 59 Mindplaces3 globally, helping us in making high-quality mental healthcare accessible to more people.
- We have continued to expand our genomics capabilities, introducing pharmacogenomic testing, polygenic risk testing and whole genome sequencing across selected markets. Last year, we also launched what is now Europe’s largest whole genome sequencing programme by a private healthcare company.
Read the Bupa Group 2026 half year financial results statement.
Enquiries
Media: Duncan West (Corporate Affairs): [email protected]
Investors: Mike Lunn (Treasury): [email protected]
About Bupa
Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company and we served 68 million customers worldwide in 20254. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Türkiye, Brazil, Mexico and India. We also have associate businesses5 in Saudi Arabia.
1 We launched our 3x100 Strategy at the start of 2025 which guides and focuses Bupa’s Market Units and Business Units on the same key priorities.
2 Combined Operating Ratio (COR) for our fully consolidated businesses is calculated based on “Insurance service expense” plus “Net expense from reinsurance contracts held” divided by “Insurance revenue” as shown in the Consolidated Income Statement.
3 Includes six pre-existing Harmonia centres in Poland established before 2025.
4 As reported at full year 2025 which includes a full 12 month of provision customers served.
5 Refers to Bupa Arabia and My Clinic.
